Research progress on serological markers of non-alcoholic fatty liver disease
10.3760/cma.j.cn101721-20230916-00074
- VernacularTitle:非酒精性脂肪性肝病的血清学标志物研究进展
- Author:
Mei LI
1
;
Rongqi WANG
Author Information
1. 河北医科大学第三医院中西医结合肝病科，石家庄 050051
- Keywords:
Non-alcoholic fatty liver disease;
Nonalcoholic steatohepatitis;
Non-alcoholic fatty liver fibrosis;
Serological markers;
Diagnosis
- From:
Clinical Medicine of China
2024;40(2):128-132
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing year by year, and it has become a serious public health problem that threatens human health.NAFLD patients can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), liver fibrosis, and even cirrhosis without intervention. Therefore, early diagnosis and treatment are particularly important.Liver biopsy is the gold standard for diagnosing NAFLD, but its limitations such as invasion, bleeding, and high cost limit its widespread clinical application. There is an urgent need for sensitive and convenient non-invasive diagnostic methods to achieve early diagnosis and treatment of NAFLD.This article provides a review of the progress in serological diagnostic methods for NAFLD both domestically and internationally in recent years.
